Insider · CIK 0001362520
Arlene Morris
director
Files at PTN (PALATIN TECHNOLOGIES INC), VRDN (Viridian Therapeutics, Inc.\DE), COGT (Cogent Biosciences, Inc.), EWTX (Edgewise Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | PTN PALATIN TECHNOLOGIES INC | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +2,400 | $0.00 | $0 | 3,527 | Dec 11, 2025 |
| Dec 9, 2025 | PTN PALATIN TECHNOLOGIES INC | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +2,400 | $0.00 | $0 | 5,927 | Dec 11, 2025 |
| Jul 1, 2025 | VRDN Viridian Therapeutics, Inc.\DE | AGrant or award Stock Option (Right to Buy)derivative | +21,000 | $0.00 | $0 | 21,000 | Jul 2, 2025 |
| Jun 16, 2025 | EWTX Edgewise Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 18, 2025 |
| Jun 4, 2025 | COGT Cogent Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +44,700 | $0.00 | $0 | 44,700 | Jun 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.